Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Ampligen in Chronic Fatigue Syndrome
This study is currently recruiting participants.
Study NCT00215813   Information provided by Hemispherx Biopharma
First Received: September 16, 2005   Last Updated: October 24, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Fatigue Syndrome
Additional conditions recognized in this trial
Fatigue
Fatigue Syndrome, Chronic
Syndrome
More general conditions related to this trial
Central Nervous System Diseases
Disease
Encephalomyelitis
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Pathologic Processes
Signs and Symptoms
Virus Diseases
Interventions listed in this trial
Ampligen (poly I: poly C12U)
Additional drug interventions recognized in this trial
Ampligen
Poly I-C
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Immunologic Factors
Interferon Inducers
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Hemispherx Biopharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services